Development and validation of a novel N6-methyladenosine (m6A)-related multi- long non-coding RNA (lncRNA) prognostic signature in pancreatic adenocarcinoma-Reference-Cited by-同舟云学术

Development and validation of a novel N6-methyladenosine (m6A)-related multi- long non-coding RNA (lncRNA) prognostic signature in pancreatic adenocarcinoma

Published:2021-01-01 Issue:1 Volume:12 Page:2432-2448
ISSN:2165-5979
Container-title:Bioengineered
language:en
Short-container-title:Bioengineered

Author:

Yuan Qihang¹²,Ren Jie³,Li Lunxu¹²,Li Shuang¹²,Xiang Kailai¹²,Shang Dong¹²

Affiliation:

1. Department of General Surgery, First Affiliated Hospital of Dalian Medical University, Dalian, China

2. Clinical Laboratory of Integrative Medicine, First Affiliated Hospital of Dalian Medical University, Dalian, China

3. Department of Oncology, First Affiliated Hospital of Dalian Medical University, Dalian, China

Funder

National Key Research and Development Program of China

National Natural Science Foundation of China

Universities in Liaoning Province

Key Project of Foreign training Program of Colleges and Universities in Liaoning Province

Publisher

Informa UK Limited

Subject

Applied Microbiology and Biotechnology,General Medicine,Bioengineering,Biotechnology

Link

https://www.tandfonline.com/doi/pdf/10.1080/21655979.2021.1933868

Reference51 articles.

1. Pancreatic cancer associated with obesity and diabetes: an alternative approach for its targeting

2. Pancreatic cancer and obesity: epidemiology, mechanism, and preventive strategies

3. Ten hub genes associated with progression and prognosis of pancreatic carcinoma identified by co-expression analysis

4. Diagnostic, progressive and prognostic performance of m6A methylation RNA regulators in lung adenocarcinoma

5. Topology of the human and mouse m6A RNA methylomes revealed by m6A-seq

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Machine learning-based identification of biomarkers and drugs in immunologically cold and hot pancreatic adenocarcinomas;Journal of Translational Medicine;2024-08-16

2. Development and validation of neutrophil extracellular traps-derived signature to predict the prognosis for osteosarcoma patients;International Immunopharmacology;2024-01

3. A novel sphingolipid metabolism-related long noncoding RNA signature predicts the prognosis, immune landscape and therapeutic response in pancreatic adenocarcinoma;Heliyon;2024-01

4. Unlocking the predictive potential of long non-coding RNAs: a machine learning approach for precise cancer patient prognosis;Annals of Medicine;2023-11-20

5. Single-cell analysis reveals exosome-associated biomarkers for prognostic prediction and immunotherapy in lung adenocarcinoma;Aging;2023-10-24